Spinout Active LTD

Company profile

Retendon Limited

UK company 13526712, incorporated on 23 July 2021.

Retendon

Retendon Limited is a UK company with status active founded in 2021 based in East Midlands.

Company number
13526712
Incorporated
23 Jul 2021
Companies House status
Active

Company identity

Browse spinouts
Founded / incorporated
23 July 2021

Company number 13526712

Verify at Companies House
Legal name
RETENDON LIMITED
Company type
LTD
Region
East Midlands
Registered address
Unknown
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

1 event
23 Jul
2021

Incorporated

Inception

Company registered at Companies House

Spinout profile

4 entries

Company description

ReTendon develops a medical device designed to aid in the rebuilding of severed tendons.

https://retendon.com This patent-protected work (patents 2008, 2019) draws on breakthrough UK research at the University of Manchester and will be further developed and commercialised by ReTendon. Investment from NLC Healthcare Venture Ltd with The University of Manchester to translate technology from this grant.

Project impact

Improved healthcare benefits for patients who need tendons reattaching. RITRS would enable patients earlier movement, much better range of motion &smaller wounds, leading to 1) more satisfactory outcome, 2) reduced burden of reoperation,&3) faster recovery & reduced follow-up required (potentially by 50%) Improved health economics for NHS Improved economy for UK as potential industry translation likely due to recent HoT with NLC Healthcare

£25k funding won November 2021 to from Wellcome Access to Expertise translation funding at The University of Manchester to fund Regulatory contractors to perform GAP analysis on data obtained ready for clinical trial funding application.

ReTendon
2021
ReTendon
2021
ReTendon
2021
RETENDON LIMITED
2021

Public funding

1 award
First funded
2023
Funded years
2023
Age at first award
1 years

Projects

2023 Collaborative R&D Lead participant

ReTendon: development of a novel tendon repair device that accelerates healing and reduces re-rupture of tendons

1 May 2023 to 30 Apr 2024

Awarded
£342,348
Total cost £489,068

The aim of this project is to **develop a novel tendon repair medical device that improves health outcomes in patients with tendon injuries**. Tendon injuries can be severely disabling to patients, often requiring an operation with long rehabilitation times and high healthcare costs. The most common types of tendon injuries that require surgical repair ar...

Product types

Collaborative R&D